U.S. Interactive Media and Services Stock News

Hormel Foods (HRL) opened fiscal Q1 2026 with revenue of about US$3.0 billion and basic EPS of US$0.33, setting a clear snapshot of where the business stands as earnings season gets underway. The company has seen quarterly revenue move in a tight band around US$3.0 billion over the past year, while basic EPS has ranged from a loss of roughly US$0.10 in Q4 2025 to US$0.40 in Q4 2024. This gives investors a mixed but data rich backdrop for judging this quarter. With trailing net profit margin...

Climb Global Solutions (CLMB) closed FY 2025 with fourth quarter revenue of US$193.8 million and basic EPS of US$1.54, as investors weighed these results against its recent 17.5% earnings growth over the past year. The company has seen quarterly revenue move from US$161.8 million and EPS of US$1.52 in Q4 2024 to US$193.8 million and EPS of US$1.54 in Q4 2025. Trailing twelve month EPS reached US$4.71 on revenue of US$652.5 million, setting the stage for investors to balance earnings momentum...

Summit Hotel Properties FY 2025 earnings: revenue steady as EPS remains in the red Summit Hotel Properties (INN) has wrapped up FY 2025 with fourth quarter revenue of US$175 million and basic EPS of a US$0.05 loss, keeping the focus firmly on how its income statement is holding up against ongoing pressures. The company has seen quarterly revenue move from US$172.9 million in Q4 2024 to US$175 million in Q4 2025, while basic EPS shifted from US$0.01 to a loss of US$0.05 over the same period,...

SEACOR Marine Holdings (SMHI) closed FY 2025 with Q4 revenue of US$52.3 million and a basic EPS loss of US$0.57, while the trailing 12 month figures show revenue of US$227.8 million and a basic EPS loss of US$1.06. Over the past six quarters, the company has seen quarterly revenue move between US$52.3 million and US$69.8 million, with EPS ranging from a loss of US$0.94 to a profit of US$0.35. This puts the latest results in the context of uneven profitability and tight margins. For investors,...

TWFG (TWFG) has just posted its FY 2025 numbers, with Q4 revenue at US$68.8 million and basic EPS of US$0.18. This caps off a trailing twelve month profile that includes revenue of US$247.1 million and basic EPS of US$0.51 alongside reported earnings growth of 179.5% over the past year. The company has seen revenue rise from US$49.5 million in Q4 2024 to US$68.8 million in Q4 2025, while quarterly EPS has moved from US$0.11 to US$0.18. This sets the backdrop for analyst forecasts that point...

Snowflake (SNOW) just closed out FY 2026 with fourth quarter revenue of US$1.3 billion and a basic EPS loss of US$0.90, alongside net income excluding extra items of a US$309.6 million loss. Over recent periods the company has seen quarterly revenue move from US$986.8 million in Q4 FY 2025 through US$942.1 million and US$1.0 billion to US$1.1 billion and US$1.2 billion before reaching US$1.3 billion, while basic EPS losses ranged between about US$0.86 and US$1.29 per share. The headline story...

Ingevity (NGVT) posts mixed FY 2025 finish as earnings swing Ingevity (NGVT) just closed FY 2025 with Q4 revenue of US$255.1 million and basic EPS of a US$2.21 loss, a sharp contrast to Q4 FY 2024 when revenue was US$298.8 million and EPS was US$0.46. Over recent quarters the company has seen revenue move from US$340.1 million in Q1 2024 to US$284 million in Q1 2025, and from US$333.8 million in Q3 2024 to US$333.1 million in Q3 2025. Quarterly EPS has ranged from a US$1.54 loss in Q1 2024 to...

Koppers Holdings (KOP) has wrapped up FY 2025 with fourth quarter revenue of US$432.7 million and basic EPS of US$1.52, while trailing twelve month figures show revenue of about US$1.9 billion and EPS of US$2.82. Over recent periods, quarterly revenue has ranged from US$456.5 million to US$504.8 million in FY 2025, with basic EPS moving from a loss of US$0.68 in Q1 2025 to US$1.21 in Q3 2025 and US$1.12 in Q3 2024. This sets up a story where modest earnings growth, a 3% net margin and a low...

Arcutis Biotherapeutics (ARQT) has just posted higher top and bottom line figures for FY 2025, with Q4 revenue of US$129.5 million and basic EPS of US$0.14, alongside net income of US$17.4 million. The company’s quarterly revenue moved from US$44.8 million in Q3 2024 to US$65.8 million in Q1 2025 and then to US$99.2 million and US$129.5 million in Q3 and Q4 2025. Basic EPS shifted from a loss of US$0.33 in Q3 2024 to a profit of US$0.06 in Q3 2025 and US$0.14 in Q4 2025, putting improving...

Latest FY 2025 Earnings Snapshot Catalyst Pharmaceuticals (CPRX) just wrapped up FY 2025 with Q4 revenue of US$152.6 million and basic EPS of US$0.43, alongside net income of US$52.7 million, putting concrete numbers around its latest earnings season update. The company has seen quarterly revenue move from US$141.8 million in Q4 2024 to US$152.6 million in Q4 2025, while basic EPS shifted from US$0.47 to about US$0.43 over the same periods. Trailing twelve month EPS stands at US$1.75 and...

Standard Motor Products (SMP) has wrapped up FY 2025 with fourth quarter revenue of US$385.1 million and basic EPS of US$0.42, against prior year Q4 revenue of US$343.4 million and basic EPS of about a US$0.04 loss. Over the last twelve months, revenue has moved from US$1.46 billion to US$1.79 billion, while trailing basic EPS has shifted from US$2.46 to US$3.59. With net profit margin at 4.4% and the latest results pointing to sturdier profitability, the focus now is on how durable these...

Hertz Global Holdings (HTZ) closed FY 2025 with Q4 revenue of US$2,028 million and a basic EPS loss of US$0.62, alongside trailing 12 month revenue of US$8.5 billion and a net loss of US$747 million. The company has seen quarterly revenue range from US$1,813 million to US$2,478 million over the last four reported periods, while basic EPS has swung between a loss of US$1.44 and a profit of US$0.59. This backdrop is prompting investors to focus on how much of that volatility is flowing through...

If you are wondering whether Royalty Pharma's current share price reflects its true worth, you are not alone and that is exactly what this article will help you unpack. The stock recently closed at US$45.36, with returns of 0.6% over 7 days, 11.3% over 30 days, 16.7% year to date, 39.2% over 1 year, 39.3% over 3 years and 20.4% over 5 years, which naturally raises questions about how much of this performance is already priced in. Recent news around Royalty Pharma has largely focused on its...

If you are wondering whether Packaging Corporation of America is still reasonably priced after its recent run, this article will walk through what the current share price could imply about value. The stock last closed at US$231.83, with returns of 3.7% over 30 days and 9.8% year to date, while the 1 year and 3 year returns stand at 12.8% and 79.0% respectively and the 5 year return is 100.5%. Recent coverage around the company has kept attention on how the packaging sector is positioned...

Wave Life Sciences (WVE) has just closed out FY 2025 with fourth quarter revenue of US$17.2 million, a basic EPS loss of US$0.30 and net income loss of US$53.2 million, following a prior year fourth quarter that carried revenue of US$83.7 million and basic EPS of US$0.18. Over recent quarters the company has seen revenue move from US$9.2 million in Q1 2025 to US$8.7 million in Q2 and US$7.6 million in Q3, while quarterly basic EPS held in a relatively tight loss range between US$0.29 and...

Ardagh Metal Packaging (NYSE:AMBP) has wrapped up FY 2025 with fourth quarter revenue of US$1.3b and a basic EPS loss of US$0.03, alongside net income excluding extra items of a US$16m loss. Over recent periods the company has seen revenue move from US$1.2b in Q4 2024 to US$1.3b in Q4 2025, with quarterly EPS ranging between a loss of US$0.03 and a profit of roughly US$0.04, while trailing twelve month net income excluding extra items sits at US$11m on US$5.5b of revenue. With the company now...

Are you wondering whether Cabot shares offer good value at today's price, or whether you might be overpaying for the story the market is telling right now? The stock last closed at US$75.81, with returns of 1.2% over the past week, 5.9% over the past month, 13.1% year to date, an 8.6% decline over the past year, a 1.6% decline over three years, and 72.7% over five years. This pattern hints that the market's view of risk and opportunity around Cabot has shifted over time. Recent news coverage...

Sirius XM Holdings' subsidiary has launched an upsized $1.25b senior notes offering. The company is also conducting a cash tender offer for its outstanding 2026 notes. The transactions are aimed at adjusting the company's existing debt profile. Sirius XM Holdings, listed on NasdaqGS:SIRI, is reshaping part of its balance sheet with this new debt issuance and tender offer. The stock trades at $21.52, with returns of 2.3% over the past week and 6.6% over the past month, while the 1 year and...

York Space Systems (YSS) has been drawing fresh attention after reporting annual revenue of $357.46 million alongside a net income loss of $90.647 million. This combination naturally raises questions about how the stock’s current pricing reflects its risk and potential. See our latest analysis for York Space Systems. With the share price at $26.17, York Space Systems has recorded a 1-day share price return of a 1.10% decline, a 7-day share price return of an 8.40% decline, and a year-to-date...

Enovix (ENVX) closed FY 2025 with Q4 revenue of US$11.3 million, a basic EPS loss of US$0.16 and a net income loss of US$35.0 million. Over recent quarters the company has seen revenue move from US$9.7 million in Q4 2024 to US$11.3 million in Q4 2025, while quarterly basic EPS shifted from a loss of US$0.20 to a loss of US$0.16. This sets the stage for investors to focus on how quickly margins might tighten or widen from here. See our full analysis for Enovix. With the headline numbers on the...

Northern Oil and Gas (NOG) FY 2025 earnings snapshot Northern Oil and Gas (NOG) has wrapped up FY 2025 with fourth quarter revenue of US$419.9 million and a basic EPS loss of US$0.73, while on a trailing twelve month basis revenue sits at about US$2.0 billion and EPS is US$0.40. Over recent periods, revenue has moved from US$506.6 million and EPS of US$0.72 in Q4 2024 to the latest Q4 2025 figures. Trailing EPS has stepped down from US$5.21 a year earlier to US$0.40 now. With net profit...

Installed Building Products FY 2025 Earnings Snapshot Installed Building Products (IBP) has wrapped up FY 2025 with fourth quarter revenue of US$747.5 million and basic EPS of US$2.85, alongside net income excluding extra items of US$76.6 million as the market weighs the results against a share price of US$322.01. Over recent quarters, the company has seen quarterly revenue move between US$684.8 million and US$778.2 million, while basic EPS has ranged from US$1.65 to US$2.85 and trailing 12...

Inhibikase Therapeutics (IKT) has moved into focus after fresh FDA designations and progress in its Phase 2a trial for IkT-148009 targeting Parkinson’s disease, even as ongoing financial instability remains part of the picture. See our latest analysis for Inhibikase Therapeutics. The recent FDA designations and Phase 2a progress appear to be feeding into momentum, with a 7 day share price return of 20.11% and a 90 day share price return of 37.50%, even though the 1 year total shareholder...

USA TODAY (TDAY) has just posted its FY 2025 numbers with Q4 revenue of US$585.0 million, basic EPS of a US$0.21 loss, and a net income loss of US$30.1 million. The trailing twelve month line shows basic EPS of US$0.01 on revenue of about US$2.3 billion and net income of US$1.7 million. Over recent periods, revenue has moved between US$560.8 million and US$621.3 million a quarter, while basic EPS has ranged from a loss of US$0.27 to a gain of US$0.54. This puts the latest print in the middle...